What is Moodify?
Founded in 2017 by Yigal Sharon and Dr. Yaniv Mama, Moodify is at the forefront of developing innovative active scents. Leveraging over a decade of research from the Weizmann Institute of Science, Moodify's proprietary scents non-invasively and safely influence the olfactory sense to improve user performance, well-being, and safety. Headquartered in Tel Aviv, Israel, the company has been recognized through its selection for the Capsula accelerator and participation in the Renault-Nissan Innovation Lab and DriveTLV innovation Center for Smart Mobility.
How much funding has Moodify raised?
Moodify has raised a total of $5.6M across 2 funding rounds:
Unspecified
$1.6M
Unspecified
$4M
Unspecified (2019): $1.6M with participation from Toyota AI Ventures and Next Gear Ventures
Unspecified (2021): $4M led by OurCrowd, Next Gear Venture Partners, Toyota AI Ventures, Taisho Pharmaceuticals, and Procter & Gamble
Key Investors in Moodify
OurCrowd
OurCrowd is an investment platform focused on startups and early-stage companies, providing capital and strategic support to ventures with high growth potential.
Toyota AI Ventures
Toyota Ventures is an early-stage venture capital firm specializing in frontier and climate technologies, including AI and robotics, aiming to accelerate disruptive startups.
Taisho Pharmaceuticals
Taisho Pharmaceuticals operates within the pharmaceutical sector, likely contributing expertise and capital to companies developing health and wellness solutions.
What's next for Moodify?
The substantial enterprise-level backing positions Moodify for accelerated scaling and further research and development. This strategic financing is expected to fuel the expansion of its unique scent technology into broader consumer and industrial applications. The company's focus on scientifically validated olfactory solutions suggests a future where mood enhancement and performance optimization through scent become mainstream.
See full Moodify company page